E-SELECTIN AS A BIOMARKER IN FEMALE PATIENTS WITH Β-THALASSEMIA IN AL- NAJAF PROVENCE, IRAQ
E-selectin, as identified (CD62E), is expressed on endothelial cells after stimulation with inflammation cytokines. β-Thalassemia diseases (βT) and early diagnosis are of utmost significance in the entire world population. This study was performed in the Thalassemia Center of the Al-Zahraa Educational Hospital in Al-Najaf Province, Iraq, on sixty-nine with β-thalassemia (54 βT major and 15 βT Intermedia) aged 8-40 years who transfused blood. Compared to 20 healthy volunteers as a control group. In both βT patients and healthy groups were assessed serum E-selectin levels. It was investigated the relationship with RBC, Hb, PCV, WBC, PLT, BMI, splenic status, iron, and ferritin levels. The results revealed a significant (P<0.05) decreased values of HB, RBC, P.C.V, and BMI. In contrast, values of WBC, PLT, Iron, and Ferritin were significantly increased in βT patients as compared to the healthy control groups. A significant (P<0.05) increase in serum E- Selectin level in βT patients (20.55±0.47) ng/ml to compare with the healthy group (9.16±0.50) ng/ml. Furthermore, it was a significant decrease in groups of βT major (19.87±0.42) ng/ml more than in βT intermedia (23±1.42) ng/ml. E-Selectin revealed a significant increase (P<0.05) in progress age and associated with splenectomies and underweight groups compared to splenectomies and the normal weight groups, respectively. Also, E-Selectin levels significantly positively correlated with WBC, PLT value, iron, and Ferritin levels. However, it was no significant with RBC, PCV, Hb. As a conclusion from this study, E- Selectin is an important biomarker in β-thalassemia patients can be identified as the complications associated with iron overload, inflammatory process, and endothelial dysfunction in βT disease.
Read ArticlePOTENTIAL EFFECTS OF KETOGENIC DIETS, A NARRATIVE REVIEW
Background: Ketogenic diets have a long history of therapeutic use and have recently attracted significant attention due to their promising effects on a variety of disorders. However, no definitive links have been identified. This review aims to highlight the possible impacts of ketogenic diets as well as the mechanisms involved in metabolic processes and related non-communicable metabolic diseases. Methods: For our analysis, a bibliographic review of articles about ketogenic diets and their therapeutic effect on chronic pathologies was carried out, retrieved from the scientific literature. Results and discussion: These studies found both positive and negative outcomes for the effects and implications of ketogenic diets on metabolism. Significant differences in metabolic markers such as weight, glycemia, serum lipids and lipoproteins, anthropometric measures, and hormones such as insulin, leptin, and adiponectin have been reported. In addition to changes in the microbiome that have modest to moderate concurrent effects, changes in metabolism indicate the significance of dietary changes in treating and preventing chronic non-communicable diseases. Conclusions: In this review, we present the available scientific evidence on the effects of the ketogenic diet, and thus ketone bodies, on metabolism and related chronic diseases.
Read Article